What is a stock summary page? Click here for an overview.
Business Description
Pharbaco Central Pharmaceutical JSC No 1
ISIN : VN000000PBC6
Description
Pharbaco Central Pharmaceutical JSC No 1 is a pharmaceutical company. Some of its products include Cefadroxil 250mg, Elnizol infusion drug, and Fabafixim 50.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.92 | |||||
| 9-Day RSI | 42.98 | |||||
| 14-Day RSI | 47.4 | |||||
| 3-1 Month Momentum % | 11.59 | |||||
| 6-1 Month Momentum % | 10 | |||||
| 12-1 Month Momentum % | 8.45 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharbaco Central Pharmaceutical JSC No 1 Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚«) | |||
| EPS (TTM) (â‚«) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.96 | ||
| 3-Year Sortino Ratio | -1.2 | ||
| Volatility % | 30.69 | ||
| 14-Day RSI | 47.4 | ||
| 14-Day ATR (â‚«) | 252.640511 | ||
| 20-Day SMA (â‚«) | 7925 | ||
| 12-1 Month Momentum % | 8.45 | ||
| 52-Week Range (â‚«) | 6000 - 10200 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharbaco Central Pharmaceutical JSC No 1 Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharbaco Central Pharmaceutical JSC No 1 Stock Events
| Event | Date | Price (â‚«) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharbaco Central Pharmaceutical JSC No 1 Frequently Asked Questions
What is Pharbaco Central Pharmaceutical JSC No 1(HSTC:PBC)'s stock price today?
The current price of HSTC:PBC is â‚«7700.00. The 52 week high of HSTC:PBC is â‚«10200.00 and 52 week low is â‚«6000.00.
When is next earnings date of Pharbaco Central Pharmaceutical JSC No 1(HSTC:PBC)?
The next earnings date of Pharbaco Central Pharmaceutical JSC No 1(HSTC:PBC) is .
Does Pharbaco Central Pharmaceutical JSC No 1(HSTC:PBC) pay dividends? If so, how much?
Pharbaco Central Pharmaceutical JSC No 1(HSTC:PBC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers